Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

Second quarter revenues of $2.34 billion, down 4.7% from 2022 Second quarter reported diluted earnings per share (“EPS”) of $2.05, up 4.6% from 2022; and adjusted diluted EPS of $2.30, down 2.5% from 2022 Second quarter base business revenues of $2.30 billion, up 9.5% from 2022 Full year…